2019 ATTENDEES
2019 Participants registered up to 19.09.2019:
| 39ytu – Instituto Central Lechera Asturiana para la Nutrición Personalizada |
| 3DforScience – Visuals for Bio&Health |
| ABVANCE |
| ACKERMANN EXECUTIVE S.L. |
| ACKERMAN MIDDLE MANAGEMENT S.L. |
| ADAN MEDICAL INNOVATION |
| ADL BIONATUR SOLUTIONS |
| ADmit THERAPEUTICS |
| ALANTRA |
| ADVANCED MARKER DISCOVERY |
| ALLINKY BIOPHARMA |
| ALMIRALL |
| ALSENS TECH |
| ALTA LIFE SCIENCES |
| ALTERNATIVE GENE EXPRESSION S.L. |
| ANDALUSIAN NETWORK FOR DESIGN AND TRASLATION OF ADVANCED THERAPIES |
| ANILING |
| ANKAR PHARMA |
| ANTARES CONSULTING |
| AORTYX |
| APTATARGETS |
| ASABYS PARTNERS |
| ASCENT BUSINESS ADVISORS |
| ASCRI – The Spanish Venture Capital & Private Equity Association |
| ASEBIO – ASOCIACIÓN ESPAÑOLA DE BIOEMPRESAS |
| ATRYS HEALTH |
| AZUCARERA IBERIA |
| BANCO SABADELL |
| BASQUE HEALTH CLUSTER |
| BDI Biotech (Biotechnology Development for Industry in Pharmaceuticals) |
| BEABLE CAPITAL SGEIC |
| BEONCHIP |
| BIEL GLASSES |
| BIOCAT |
| BIOCREW LIFE SCIENCE |
| BIOCROSS |
| BIOGA |
| BIOGENERATION VENTURES |
| BIOHOPE |
| BIOMEDICA MOLECULAR MEDICINE S.L. |
| BIONCOTECH |
| BIOPOLO LA FE |
| BIOSEARCH |
| BME / MAB – SPANISH STOCK EXCHANGE |
| CANAAN RESEARCH |
| CANCERAPPY |
| CAPITAL CELL |
| CARTAGO VENTURES |
| CDTI – CENTRE FOR INDUSTRIAL TECHNOLOGICAL DEVELOPMENT |
| CELLUS BIOMEDICA EU |
| CENTRO DE INVESTIGACION BIOMEDICA EN RED (CIBER) |
| CHECKPOINT PARTNERS |
| CIC bioGUNE |
| CIC nanoGUNE |
| CLAVE MAYOR |
| CNIO – SPANISH NATIONAL CANCER RESEARCH CENTRE |
| COLUMBUS VENTURE PARTNERS |
| CONSULATE OF CANADA IN BARCELONA |
| CRB Inverbío |
| CTI LIFE SCIENCES |
| DEMETER PARTNERS |
| DROPLITE |
| EBERS MEDICAL TECHNOLOGY |
| EIT HEALTH |
| ELCODE – TECNALIA |
| ELEM BIOTECH |
| ENTRECHEM |
| EPIC CAPITAL MANAGEMENT |
| EURONEXT |
| EUROPEAN BIOTECHNOLOGY NEWS |
| EUROPEAN INVESTMENT BANK |
| EVERSENS |
| EVOLGENE |
| EXELTIS – INSUD PHARMA |
| FIBICO – FUNDACION PARA LA INVESTIGACION BIOMEDICA DE CORDOBA |
| FUND + |
| FUNDACION CIENTÍFICA DE LA ASOCIACIÓN ESPAÑOLA CONTRA EL CANCER |
| FUNDACION SHIP2B |
| GALEA THERAPEUTICS |
| GALEON INTERNATIONAL |
| GENESIS BIOMED |
| GENETRACER |
| GOMEZ-ACEBO & POMBO ABOGADOS |
| GREENALTECH |
| GVC GAESCO |
| GRIFOLS |
| HASTEN VENTURES |
| HISTOCELL |
| ICEX – INVEST IN SPAIN |
| IKAN BIOTECH |
| ILANA Capital |
| ILDEFE / LEON UP |
| INBIOTEC – BIOTECHNOLOGY INSTITUTE OF LEON |
| INNITIUS |
| INNOUP PHARMA |
| INNOPRICK |
| INSTITUTO BIOMAR |
| INSTITUTO DE INVESTIGACIÓN MULTIDISCIPLINAR EN BIOLOGÍA APLICADA (IMAB) |
| INSTITUTO PARA LA COMPETITIVIDAD EMPRESARIAL DE CASTILLA Y LEON |
| INVEREADY |
| INVIVO CAPITAL PARTNERS |
| INYCOM BIOTECH |
| IPF PARTNERS |
| ISQUAEMIA BIOTECH, S.L. |
| ITALFARMACO GROUP |
| JOHNSON & JOHNSON INNOVATION |
| JORGE GARCÍA GALDUROZ |
| KAUDAL TECHNOLOGY INVESTMENT |
| LA BOLSA SOCIAL |
| LABIANA LIFE SCIENCES |
| LABORATORIOS RUBIO |
| LAMINAR PHARMACEUTICALS |
| LIPOTEC |
| LIFE LENGHT |
| LIMNO PHARMA |
| MAQUA CAPITAL |
| MEDMESAFE |
| MERCK, SHARP & DOHME |
| MICROVIABLE THERAPEUTICS |
| MJN NEUROSERVEIS |
| MOLOMICS |
| NANOLIGENT |
| NEUROFIX PHARMA |
| OMNES CAPITAL |
| ONA THERAPEUTICS |
| ORYZON GENOMICS |
| OUR CROWD |
| OXOLIFE |
| PARC CIENTIFIC DE BARCELONA |
| PARQUE CIENTIFICO DE MADRID |
| PARQUE TECNOLOGICO DE LA SALUD DE GRANADA |
| PHARMACELERA |
| PHARMACTIVE BIOTECH PRODUCTS |
| PINSENT MASONS |
| PRAXIS PHARMACEUTICALS |
| PROEXCA |
| PROTEIN ALTERNATIVES |
| Q-REM |
| REMAB |
| RENTA4 |
| RHEO DIAGNOSTICS |
| ROIVANT SCIENCES |
| SOCIEDAD DE PROMOCIÓN ECONÓMICA DE GRAN CANARIA |
| SODENA |
| SOLVENTIS |
| SOM BIOTECH |
| SUNROCK BIOSCIENCES |
| SYLENTIS |
| TABY DIAGNOSTICS |
| TECNALIA VENTURES |
| TETRANEURON |
| TOALCLA |
| UNINVEST |
| UNIVERSITAT POMPEU FABRA VENTURES |
| VENTAC PARTNERS |
| VIROMII INNOVATION |
| VISCOFAN |
| VLP VACCINES |
| WE CUBED PARTNERS |
| YSIOS CAPITAL |
| ZCARDIO TX |
| ZENDAL |
